Cargando…
Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer
OBJECTIVE: Personalized chemotherapy based on predictive biomarkers can maximize efficacy. However, tumor tissue obtained at the time of initial diagnosis will not reflect genetic alterations observed at the time of disease progression. We have examined whether plasma mRNA levels can be a surrogate...
Autores principales: | Shen, Jie, Wei, Jia, Guan, Wenxian, Wang, Hao, Ding, Yitao, Qian, Xiaoping, Yu, Lixia, Zou, Zhengyun, Xie, Li, Costa, Carlota, Bivona, Trever, Rosell, Rafael, Liu, Baorui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302091/ https://www.ncbi.nlm.nih.gov/pubmed/25496700 http://dx.doi.org/10.1186/s12967-014-0355-2 |
Ejemplares similares
-
A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer
por: Shen, Jie, et al.
Publicado: (2013) -
Synergistic Anticancer Effects of Polyphyllin I and Evodiamine on Freshly-Removed Human Gastric Tumors
por: Yue, Guofeng, et al.
Publicado: (2013) -
Therapeutic effect and safety of individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer
por: Du, Juan, et al.
Publicado: (2022) -
The plasma levels of 12 cytokines and growth factors in patients with gastric cancer
por: Zou, Zhengyun, et al.
Publicado: (2018) -
The Prognostic Value of BRCA1 mRNA Expression Levels Following Neoadjuvant Chemotherapy in Breast Cancer
por: Margeli, Mireia, et al.
Publicado: (2010)